Durvalumab,Monalizumab,Oleclumab,Ceralasertib,DOCETAXEL,Savolitinib
AstraZeneca,Innate,Sanofi,Aventis,hutchmed
['thanks', 'biomarker', 'lung', 'nsclc', 'ca,022,i', 'sclc', 'pioneer', 'bms']
#esmoimmuno22 presenting pioneer trial - a model to investigate bmk of response to cpi in nsclc 